AstraZeneca Q3 revenue up 7% as cancer drugs offset Farxiga drop
In
Investing.comBy Investing.com10/30/2026, 7:32:09 AM
EXECUTIVE SUMMARY
AstraZeneca Q3 revenue up 7% as cancer drugs offset Farxiga drop....
Key Takeaways
- AstraZeneca Q3 revenue up 7% as cancer drugs offset Farxiga drop.
Read Complete Original Article
Published originally on Investing.com
Related News
finance4 minutes ago
Chinese spy or chump? The case of the Fed economist
Chinese spy or chump? The case of the Fed economist The Economist
finance8 minutes ago
AMD stock falls as Intel’s weak PC outlook weighs on sector
AMD stock falls as Intel’s weak PC outlook weighs on sector Investing.com Australia
finance8 minutes ago
Sparebanken Norge shares fall after net interest income drops By Investing.com
Sparebanken Norge shares fall after net interest income drops By Investing.com Investing.com Australia
finance9 minutes ago
Energy rally lifts FTSE 100 to lone gain in Europe as oil approaches 6-month high
Energy rally lifts FTSE 100 to lone gain in Europe as oil approaches 6-month high Investing.com Australia
Multikhabar App
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!